Inventor · Berwyn, PA, US

Michael Rycyzyn

21Patents
5h-index
21Co-inventors
69Inventor score

Filing activity: Aug 10, 2000 → Nov 9, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US7491391B2 Anti-IL-23 antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 60 Active
US7807414B2 Anti-IL-23 antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 29 Active
US9102737B2 Human anti-CD27 antibodies, methods and uses Chemistry; Metallurgy 26 Active
US9683046B2 Nucleic acid molecules encoding anti-CD27 antibodies Chemistry; Metallurgy 7 Active
US7479379B2 Methods for altering protein production rates Chemistry; Metallurgy 5 Expired
US10301392B2 Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies Chemistry; Metallurgy 2 Active
US10272152B2 Anti-IL-23 antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 1 Active
US10576150B2 Anti-IL-23 antibodies Emerging Cross-Sectional Technologies 1 Active
US8574579B2 Anti-IL-23 antibodies Emerging Cross-Sectional Technologies 1 Active
US11732050B2 Neutralizing human anti-CD27 antibodies Chemistry; Metallurgy 0 Active
US8216842B2 Enhancement of hybridoma fusion efficiencies through cell synchronization Chemistry; Metallurgy 0 Active
US11185584B2 Anti-IL-23 antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 0 Active
US7902341B2 Methods and compositions for modulating somatolactogenic functions Physics 0 Active
US10689453B2 Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies Chemistry; Metallurgy 0 Active
US6979673B1 Method and compositions for modulating somatolactogenic functions Human Necessities 0 Expired
US12161716B2 Anti-IL-23 antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 0 Active
US7105306B1 Methods and compositions for modulating somatolactogenic functions Physics 0 Expired
US9096667B2 Anti-IL-23 antibodies, compositions, methods and uses Emerging Cross-Sectional Technologies 0 Active
US9714287B2 Anti-IL-23 antibody compositions Emerging Cross-Sectional Technologies 0 Active
US9505837B2 Anti-IL-23 antibodies Emerging Cross-Sectional Technologies 0 Active
US9127058B2 Anti-IL-23 Antibodies Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.